IRIDEX CORP Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
IRIDEX CORP (IRIX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$9.20 million for the 9-month period ending 2016-10-01, per its 10-Q filed 2016-11-07.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2016-11-07
- IRIDEX CORP valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2016-10-01 was $0.00.
- IRIDEX CORP valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2016-07-02 was $0.00.
- IRIDEX CORP valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2016-04-02 was -$9.20M.
- IRIDEX CORP valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2015-10-03 was $0.00.
- IRIDEX CORP valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was -$9.20M, a 10674.71% decline from fiscal 2013.
- IRIDEX CORP valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2013 was $87.00K, a 94.56% decline from fiscal 2012.
- IRIDEX CORP valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2012 was $1.60M, a 286.47% increase from fiscal 2011.
- IRIDEX CORP valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2011 was $414.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|---|---|
| 2016-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | -$9.20M 10-Q · filed 2016-11-07 | |
| 2016-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$9.20M 10-Q · filed 2016-08-08 | ||
| 2016-04-02 | -$9.20M 10-Q · filed 2016-05-09 | |||
| 2015-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $0.00 derived: sum of 2 quarters · filed 2015-11-10 | -$9.20M 10-Q · filed 2015-11-10 | |
| 2015-07-04 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$9.20M 10-Q · filed 2015-08-10 | ||
| 2015-04-04 | -$9.20M 10-Q · filed 2015-05-12 | |||
| 2015-01-03 | -$9.20M 10-K · filed 2015-04-02 | |||
| 2013-12-28 | $87.00K 10-K · filed 2014-03-27 | |||
| 2012-12-29 | $1.60M 10-K · filed 2014-03-27 | |||
| 2011-12-31 | $414.00K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |